SCHEMBL7976497

SCHEMBL7976497

CCC(Oc1ccc2c(c1)Cc1sc(S)nc1-2)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 13/20 0.47
ALDH1A1 P00352 6/20 0.47
SMN1; SMN2 Q16637 6/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
TDP2 O95551 2/20 0.47
HSD17B10 Q99714 2/20 0.47
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
APAF1 O14727 4/20 0.46
KDM4E B2RXH2 2/20 0.46
HPGD P15428 1/20 0.46
TP53 P04637 5/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
BLM P54132 2/20 0.45
CASP3 P42574 1/20 0.45
MCL1 Q07820 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7962810 0.90 MAPT (0.47) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL7962751 0.86 MAPT (0.46) MAPTALDH1A1SMN1; SMN2HSD17B10MEN1
SCHEMBL7520588 0.79 HSD17B10 (0.52) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL7974210 0.77 ADORA1 (0.41) MAPTSMN1; SMN2NPC1RAB9AMEN1
SCHEMBL7976456 0.72 PPARA (0.39) MAPTSMN1; SMN2NPC1RAB9AKMT2A
SCHEMBL7972627 0.72 SMN1; SMN2 (0.38) SMN1; SMN2PPARGPPARA
SCHEMBL7974342 0.71 PPARA (0.38) SMN1; SMN2CYP3A4PPARGPPARA
SCHEMBL7962725 0.70 SMN1; SMN2 (0.58) SMN1; SMN2MEN1KMT2APPARGPPARA
SCHEMBL7528931 0.69 FBP1 (0.54) MAPTALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL7972777 0.68 SMN1; SMN2 (0.56) SMN1; SMN2PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248766-B1 CARDIOVASCULAR DISORDERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-06-19 US disclosed
EP-0929534-A1 TRYCYCLIC COMPOUNDS AS PROSTAGLANDIN I2 RECEPTOR AGONISTS Takeda Pharmaceutical Company Limited (JP) 1999-07-21 EP disclosed
WO-1998013356-A1 TRYCYCLIC COMPOUNDS AS PROSTAGLANDIN I2 RECEPTOR AGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-04-02 WO disclosed